BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15041471)

  • 1. Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1).
    Hooijberg JH; Jansen G; Assaraf YG; Kathmann I; Pieters R; Laan AC; Veerman AJ; Kaspers GJ; Peters GJ
    Biochem Pharmacol; 2004 Apr; 67(8):1541-8. PubMed ID: 15041471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folates provoke cellular efflux and drug resistance of substrates of the multidrug resistance protein 1 (MRP1).
    Hooijberg JH; Jansen G; Kathmann I; Pieters R; Laan AC; van Zantwijk I; Kaspers GJ; Peters GJ
    Cancer Chemother Pharmacol; 2014 May; 73(5):911-7. PubMed ID: 24595806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between the ability of some compounds to modulate the MRP1-mediated efflux of glutathione and to inhibit the MRPl-mediated efflux of daunorubicin.
    Salerno M; Loechariyakul P; Saengkhae C; Garnier-Suillerot A
    Biochem Pharmacol; 2004 Dec; 68(11):2159-65. PubMed ID: 15498506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1).
    Holland ML; Allen JD; Arnold JC
    Eur J Pharmacol; 2008 Sep; 591(1-3):128-31. PubMed ID: 18619955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate receptor targeted delivery of liposomal daunorubicin into tumor cells.
    Ni S; Stephenson SM; Lee RJ
    Anticancer Res; 2002; 22(4):2131-5. PubMed ID: 12174894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport.
    Evers R; Kool M; Smith AJ; van Deemter L; de Haas M; Borst P
    Br J Cancer; 2000 Aug; 83(3):366-74. PubMed ID: 10917553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells.
    Assaraf YG; Rothem L; Hooijberg JH; Stark M; Ifergan I; Kathmann I; Dijkmans BA; Peters GJ; Jansen G
    J Biol Chem; 2003 Feb; 278(9):6680-6. PubMed ID: 12486126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo analysis of human multidrug resistance protein 1 (MRP1) activity using transient expression of fluorescently tagged MRP1.
    Rajagopal A; Pant AC; Simon SM; Chen Y
    Cancer Res; 2002 Jan; 62(2):391-6. PubMed ID: 11809686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.
    Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F
    Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
    Mankhetkorn S; Dubru F; Hesschenbrouck J; Fiallo M; Garnier-Suillerot A
    Mol Pharmacol; 1996 Mar; 49(3):532-9. PubMed ID: 8643093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is P-glycoprotein (ABCB1) a phase 0 or a phase 3 colchicine transporter depending on colchicine exposure conditions?
    Declèves X; Niel E; Debray M; Scherrmann JM
    Toxicol Appl Pharmacol; 2006 Dec; 217(2):153-60. PubMed ID: 16978677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
    Jansen G; van der Heijden J; Oerlemans R; Lems WF; Ifergan I; Scheper RJ; Assaraf YG; Dijkmans BA
    Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates.
    Wielinga P; Hooijberg JH; Gunnarsdottir S; Kathmann I; Reid G; Zelcer N; van der Born K; de Haas M; van der Heijden I; Kaspers G; Wijnholds J; Jansen G; Peters G; Borst P
    Cancer Res; 2005 May; 65(10):4425-30. PubMed ID: 15899835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1.
    Nabekura T; Yamaki T; Kitagawa S
    Eur J Pharmacol; 2008 Dec; 600(1-3):45-9. PubMed ID: 18955043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system.
    Chen ZS; Lee K; Walther S; Raftogianis RB; Kuwano M; Zeng H; Kruh GD
    Cancer Res; 2002 Jun; 62(11):3144-50. PubMed ID: 12036927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis.
    Ifergan I; Shafran A; Jansen G; Hooijberg JH; Scheffer GL; Assaraf YG
    J Biol Chem; 2004 Jun; 279(24):25527-34. PubMed ID: 15047700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance-associated protein-1 functional activity in Calu-3 cells.
    Hamilton KO; Topp E; Makagiansar I; Siahaan T; Yazdanian M; Audus KL
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1199-205. PubMed ID: 11504821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
    Kühnel JM; Chiao JH; Sirotnak FM
    J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of adaptation to folate deficiency.
    Ifergan I; Assaraf YG
    Vitam Horm; 2008; 79():99-143. PubMed ID: 18804693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals.
    Nabekura T; Yamaki T; Ueno K; Kitagawa S
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):867-73. PubMed ID: 18204840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.